Abstract
Complement factor 3 (C3) has been identified as a novel risk factor for obesity-associated cardiometabolic diseases. Data in the literature suggest th
Funding Information
  • Netherlands Organization for Scientific Research (940-35-034)
  • Dutch Diabetes Research Foundation (98-901)
  • Netherlands Heart Foundation (2006T050)

This publication has 50 references indexed in Scilit: